Quality of life in patients with primary hyperparathyroidism in the Chuvash Republic
https://doi.org/10.14341/serg12833
Abstract
Anthropometric data, indicators of laboratory and instrumental examinations were prospectively studied in 80 patients with primary hyperparathyroidism who were treated at the Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia. The quality of life of all patients with primary hyperparathyroidism was assessed before and after surgical treatment using two questionnaires: the SF-36 questionnaire and the standardized quality of life questionnaire for patients with PGPT — PHQol, an adapted Russian version of the quality of life questionnaire for primary hyperparathyroidism. As a result of the study, primary hyperparathyroidism was found to be a disease with a low level of detectability due to low awareness of practitioners, therefore, it often takes up to 10 years from the onset of the disease to diagnosis. It is necessary to introduce screening programs to determine the level of calcium in the blood. The disease primary hyperparathyroidism is of medical and economic importance, which pushes us to pay closer attention to this disease, to create a register of patients with primary hyperparathyroidism. Assessment of the quality of life before and after surgical treatment makes it possible to assess the subjective state of the patient, and also contributes to a patient-oriented approach in the management of patients with PGPT. The standardized questionnaire for assessing the quality of life in hyperparathyroidismPHQoL, its adapted and validated Russian version is a reliable method for studying the quality of life before and after surgical treatment of patients with PGPT, as well as for evaluating the effectiveness of surgical treatment.
About the Authors
G. A. Aizetullova
Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia;
I.N. Ulyanov Chuvash State University
Russian Federation
Russian Federation
Guzel R. Aizetullova
Cheboksary
V. F. Osipov
Republican Clinical Hospital for War Veterans of the Ministry of Health of Chuvashia;
I.N. Ulyanov Chuvash State University
Russian Federation
Russian Federation
Vladimir F. Osipov
Cheboksary
V. A. Kichigin
GAU DPO Institute of Advanced Medical Training
Vadim A. Kichigin
Cheboksary
References
1. Rossiiskaia assotsiatsiia endokrinologov. Klinicheskie rekomendatsii. Pervichnyi giperparatireoz. Moscow: Ministerstvo zdravookhraneniya RF; 2016. (In Russ.).
2. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959. doi: https://doi.org/10.1001/jamasurg.2016.2310
3. Mokrysheva NG. Pervichnyi giperparatireoz. Epidemiologiia, klinika, sovremennye printsipy diagnostiki i lecheniia. [dissertation] Moscow; 2011. (In Russ.).
4. Farkhutdinova LM. Pervichnyi giperparatireoz: problemy i puti resheniia. Meditsinskii vestnik Bashkortostana. 2010;5(1):65-70. (In Russ.).
5. Ferraz-de-Souza B. The evolution of primary hyperparathyroidism. Arch Endocrinol Metab. 2015;59(5):381-382. doi: https://doi.org/10.1590/2359-3997000000124
6. Dedov II, Melnichenko GA, Mokrysheva NG, et al. Primary hyperparathyroidism: the clinical picture, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2017;62(6):40-77. (In Russ.). doi: https://doi.org/10.14341/probl201662640-77
7. Valdina E.A. Zabolevaniia shchitovidnoi zhelezy: rukovodstvo. Saint Petersburg: Piter; 2006. 368 p. (In Russ.).
8. Leonard R. Sanders. Giperparatireoz. In: Makdermott MT. editor. Sekrety endokrinologii. Saint Petersburg: Izdatel’stvo BINOM — Nevskii dialekt; 2001. P. 129-140. (In Russ.).
9. Mokrysheva NG, Rozhinskaia LI, Peretokina EV, et al. The results of analysis of the major epidemiological characteristics of primary hyperparathyroidism in Russia based on the registry data. Problems of Endocrinology. 2012;58(5):16-20. (In Russ.). doi: https://doi.org/10.14341/probl201258516-20
10. Gladkova IN, Rusakov VF, Chernikov RA, et al. Validation and testing of the Russian version of PHPQoL questionnaire for quality of life assessment in patients with primary hyperparathyroidism (PHPT). Problems of Endocrinology. 2021;67(1):41-51. (In Russ.). doi: https://doi.org/10.14341/probl12714
11. Pasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: A 10-year prospective surgical outcome study. Surgery. 2009;146(6):1006-1013. doi: https://doi.org/10.1016/j.surg.2009.10.021
12. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism:summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2009;99(10):3561-3569. doi: https://doi.org/10.1210/jc.2014-1413
13. Brito K, Edirimanne S, Eslick GD. The extent of improvement of healthrelated quality of life as assessed by the SF36 and Paseika scales after parathyroidectomy in patients with primary hyperparathyroidism — A systematic review and meta-analysis. Int J Surg. 2015;(13):245-249. doi: https://doi.org/10.1016/j.ijsu.2014.12.004
14. Murray SE, Pathak PR, Schaefer SC, et al. Improvement of sleep disturbance and insomnia following parathyroidectomy for primary hyperparathyroidism. World J Surg. 2014;38(3):542-548. doi: https://doi.org/10.1007/s00268-013-2285-1
15. Webb SM, Puig-Domingo M, Villabona C, et al. Development of a new tool for assessing Health-Related Quality of Life in patients with primary hyperparathyroidism. Health Qual Life Outcomes. 2013;11(1):97. doi: https://doi.org/10.1186/1477-7525-11-97
16. Webb SM, Puig-Domingo M, Villabona C, et al. Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2016;101(4):1571-1578. doi: https://doi.org/10.1210/jc.2015-3094
17. Chiodini I, Cairoli E, Palmieri S, et al. Non classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):805-820. doi: https://doi.org/10.1016/j.beem.2018.06.006.
18. Ejlsmark-Svensson H, Rolighed L, Rejnmark L. Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism:a randomized clinical trial. J Clin Endocrinol Metab. 2019;104(8):3223-3232. doi: https://doi.org/10.1210/jc.2018-02456.
Review
For citations:
Aizetullova G.A., Osipov V.F., Kichigin V.A. Quality of life in patients with primary hyperparathyroidism in the Chuvash Republic. Endocrine Surgery. 2023;17(3):24-29. (In Russ.) https://doi.org/10.14341/serg12833
Views:
221
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
